SCHEMBL96715

SCHEMBL96715

N#Cc1ccc2c(c1)c1ccccc1c(=O)n2Cc1ccc(-c2ccccc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 1/20 0.49
PDE9A O76083 1/20 0.49
PDE1C Q14123 1/20 0.49
DPP4 P27487 2/20 0.45
HDAC1 Q13547 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
SRC P12931 1/20 0.43
PGR P06401 2/20 0.43
RORA P35398 2/20 0.43
RORC P51449 2/20 0.43
RORB Q92753 2/20 0.43
BRD4 O60885 1/20 0.42
EGLN1 Q9GZT9 1/20 0.42
CNR1 P21554 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
AR P10275 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL96088 0.92 CFTR (0.50) CFTRPDE9APDE1CHDAC1HDAC8
SCHEMBL97588 0.82 PTGER4 (0.54) DPP4PGRRORARORCRORB
SCHEMBL11754704 0.80 CYP19A1 (0.55) CFTRPDE9APDE1CHDAC1HDAC8
SCHEMBL21673067 0.71 CYP19A1 (0.49) PDE9APDE1CPGRRORCAR
SCHEMBL7098938 0.71 ALDH1A1 (0.63) CFTRHDAC1HDAC8HDAC6PGR
SCHEMBL31022838 0.71 CYP19A1 (0.63) HDAC1HDAC6RORCP2RX4LMNA
SCHEMBL17930690 0.71 CYP19A1 (0.63) HDAC1HDAC6RORCP2RX4LMNA
SCHEMBL23789536 0.71 CYP19A1 (0.64) CFTRPDE9APDE1CHDAC1HDAC8
SCHEMBL28915305 0.71 CCR2 (0.55) HDAC1HDAC8HDAC6SRCAR
SCHEMBL96124 0.70 SRC (0.51) SRCPGRRORARORCRORB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
CN-101068810-B Carbostyril compound OTSUKA PHARMA CO LTD 2011-02-09 CN disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
CN-101068810-A Carbostyril compound OTSUKA PHARMA CO LTD (JP) 2007-11-07 CN disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 CFTR 159/4885PDE9A 4146/4885PDE1C 3812/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 CFTR 159/4885PDE9A 4146/4885PDE1C 3812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.